Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Novel ITK tyrosine kinase inhibitors and their use covered by BMS patent

Aug. 13, 2002

Crucell and NIAID expand Ebola vaccine agreement to include Marburg and Lassa vaccines

Aug. 13, 2002

Adjuvant QS-21 enhances immunogenicity of malaria peptide vaccine

Aug. 6, 2002

Zonagen receives SBIR grant to study adjuvant system

Aug. 5, 2002

Marketing authorization for Triacelluvax withdrawn in E.U.

Aug. 5, 2002

New formulation of Rapamune introduced in U.K.

July 26, 2002

Plexus Vaccine and GlaxoSmithKline sign vaccine research agreement

July 25, 2002

Enrollment completed in phase II/III trial of ABX-CBL in steroid-resistant GVHD

July 24, 2002

New CB2 agonists and their use in autoimmune diseases, etc.

July 16, 2002

Abiogen and Philogen collaborate on hepatitis C and tetanus vaccines

July 16, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....